| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |